Otsuka Pharmaceutical, Co. Ltd. (Otsuka) announce today that Otsuka Precision Health, Inc. (OPH) and Click Therapeutics, Inc., (Click) have launched Rejoyn™. Rejoyn was cleared by the U.S. Food and Drug Administration (FDA) in March 2024 and is the first-and-only prescription digital therapeutic for the treatment of major depressive disorder ... More @Wikipedia
Get the latest news about Otsuka Precision Health from the top news sites, aggregators and blogs. Also included are videos, photos, and websites related to Otsuka Precision Health.
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.